Quris-AI is an artificial intelligence innovator focused on disrupting the drug development process. The company's Bio-AI Clinical Prediction Platform is designed to accurately predict which drug candidates will safely work in humans, thereby avoiding the tremendous costs of failed clinical trials.

Quris's advanced machine-learning approach generates data for classification algorithms by testing drugs on miniaturized patients-on-a-chip, after which the machine-learning model is trained using the automatically tagged data. The generated and classified data is used to continuously retrain the algorithm, which is highly predictive of clinical safety.